2.7.7.6	(NH4)2SO4	-	399	
2.7.7.6	(S)-2-((1-amino-1-oxo-3-phenylpropan-2-ylamino)methyl)-3-(4-amino phenoxy)-5-methoxy phenyl acetate	-	77929	
2.7.7.6	(S)-2-((1-amino-1-oxo-3-phenylpropan-2-ylamino)methyl)-5-methoxy-3-(4-nitrophenoxy)phenyl acetate	-	77927	
2.7.7.6	(S)-2-((1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-ylamino)methyl)-3-(4-aminophenoxy)-5-methoxyphenyl acetate	-	77928	
2.7.7.6	(S)-2-((1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-ylamino)methyl)-5-methoxy-3-(4-nitrophenoxy)phenyl acetate	-	77926	
2.7.7.6	1,3-dimethoxy-5-(4-nitrophenoxy) benzene	-	77922	
2.7.7.6	1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine	i.e. ECyd, TAS-106, a antitumor ribonucleoside that inhibits RNA polymerase, acts synergistically in inhibiting A-549 cancer cell growth and in tumor growth in vivo. The compound also inhibits the checkpoint-associated protein, the expression of Chk1 protein and the phosphorylation of Chk1 and Chk2, antitumour effects in combination with cisplatin, overview	155594	
2.7.7.6	1-[2-[3-(4-Chloro-3-trifluoromethylphenyl)ureido]-4-trifluoromethyl phenoxy]-4,5-dichlorobenzene sulfonic acid	-	16023	
2.7.7.6	2'-C-ethynyl-7-deaza-ATP	causes immediate chain termination	256911	
2.7.7.6	2'-C-Me-ATP	causes immediate chain termination	256910